MK

Moparthi Koteswara Rao

Director Director DIN 00630216
DIN 00630216 First appointment May 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2008
Shareholding value •••• Premium profile

About Moparthi Koteswara Rao

Data last updated:

Moparthi Koteswara Rao was a Director at Eshwar Pharmaceuticals Private Limited (2008–2013) and Director at Vinta Laboratories Private Limited (2012–2019). The companies operate in Pharma.

DIN 00630216
Primary Designation Director
Industry Pharma
First Appointment 14 May 2008

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 May 20082008₹3.36 Cr (FY 2018)Converted To Llp
Vinta Laboratories Private Limited U24232AP2012PTC081966
Director12 Jul 20122012₹67.23 Cr (FY 2021)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Eshwar Pharmaceuticals Private Limited
Vinta Laboratories Private Limited
Premium access

Shareholding and investment profile for Moparthi Koteswara Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Moparthi Koteswara Rao

Moparthi Koteswara Rao was first appointed on 14 May 2008 as Director at Eshwar Pharmaceuticals Private Limited. The most recent appointment on record is 12 Jul 2012 at Vinta Laboratories Private Limited.

Moparthi Koteswara Rao held 2 earlier board appointments: Eshwar Pharmaceuticals Private Limited (Director, 14 May 2008 to 31 Jan 2013); Vinta Laboratories Private Limited (Director, 12 Jul 2012 to 04 Sep 2019).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available